NHS Treating Dementia Patients Like Second-Class Citizens

By the Editorial Team · Monday, July 6, 2026

Michelle Dyson, head of the Alzheimer’s Society, condemned the NHS for providing insufficient support to dementia patients, who are often discharged with minimal guidance and without proper care plans. Her critique highlights concerns over systemic unpreparedness for new Alzheimer’s treatments and a disparity in the urgency of care compared to other serious illnesses, amid nearly one million people living with dementia in the UK.

The head of the Alzheimer’s Society has criticized the National Health Service (NHS) for inadequately supporting dementia patients, describing their treatment as akin to being regarded as second-class citizens. Michelle Dyson, a former senior official in the Department of Health, expressed concerns that individuals diagnosed with dementia are frequently discharged with minimal guidance, often receiving only informational leaflets rather than comprehensive care plans.

Dyson highlighted a disparity in how dementia is managed compared to other serious illnesses such as cancer or heart disease. She noted that while those diseases prompt urgent and proactive intervention, dementia patients often face delayed or insufficient support. “Imagine being told you have a disease that will rob you of your memory, your independence and your ability to recognise the people you love — and then being sent home with a leaflet. That would be unthinkable for cancer. Yet for dementia, it happens all the time,” Dyson said in an interview.

She further accused the NHS of being unprepared to implement new and emerging Alzheimer’s treatments, suggesting systemic shortcomings in readiness and resources. “The NHS is meant to be there for everyone who needs it but people with dementia are being cast aside and left to fend for themselves,” she added.

Currently, approximately 982,000 people in the United Kingdom live with dementia, which remains the leading cause of death in the country. The condition poses substantial challenges both for those affected and the healthcare system tasked with their care.

In response to the criticism, the Department of Health emphasized its commitment to those living with dementia, stating, “We want everyone affected [by dementia] to be able to access high-quality, personalised support.” The department did not address specific claims regarding the adequacy of current care or preparedness for new therapies.

The debate underscores ongoing concerns about how the NHS addresses neurodegenerative diseases amid growing patient numbers and evolving treatment options.

This article was reported by synthesizing coverage from multiple independent news outlets to present a balanced, unbiased account. Read about our editorial standards. Spotted an error? Let us know.